Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2008 | 09-2008 | 06-2008 | 03-2008 | 12-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,800 | -1,180 | -4,600 | -3,720 | -1,670 |
| Depreciation Amortization | 260 | 130 | 760 | 990 | 340 |
| Other Working Capital | -450 | 200 | 90 | 210 | 450 |
| Other Operating Activity | 790 | -260 | 1,350 | 980 | 220 |
| Operating Cash Flow | $-2,200 | $-1,110 | $-2,400 | $-1,540 | $-660 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | -3 | -2 | 0 |
| Other Investing Activity | -2,350 | -2,100 | -1,007 | -798 | -640 |
| Investing Cash Flow | $-2,350 | $-2,100 | $-1,010 | $-800 | $-640 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 8,680 | 5,990 | 6,030 |
| Financing Cash Flow | $0 | $0 | $8,680 | $5,990 | $6,030 |
| Beginning Cash Position | 5,670 | 5,670 | 400 | 400 | 400 |
| End Cash Position | 1,110 | 2,450 | 5,670 | 4,040 | 5,130 |
| Net Cash Flow | $-4,560 | $-3,210 | $5,260 | $3,640 | $4,720 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,200 | -1,110 | -2,400 | -1,540 | -660 |
| Free Cash Flow | -2,200 | -1,110 | -2,400 | -1,540 | -660 |